Robeco Institutional Asset Management B.V. Alnylam Pharmaceuticals, Inc. Transaction History
Robeco Institutional Asset Management B.V.
- $60.3 Billion
- Q2 2025
A detailed history of Robeco Institutional Asset Management B.V. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 96,368 shares of ALNY stock, worth $31.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
96,368
Previous 103,481
6.87%
Holding current value
$31.7 Million
Previous $27.9 Million
12.47%
% of portfolio
0.05%
Previous 0.06%
Shares
34 transactions
Others Institutions Holding ALNY
# of Institutions
724Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$5.51 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.29 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$3.14 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.35 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.45 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $40.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...